0001104659-24-062602.txt : 20240516 0001104659-24-062602.hdr.sgml : 20240516 20240516170851 ACCESSION NUMBER: 0001104659-24-062602 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240515 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240516 DATE AS OF CHANGE: 20240516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Global Medical REIT Inc. CENTRAL INDEX KEY: 0001533615 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 464757266 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37815 FILM NUMBER: 24956644 BUSINESS ADDRESS: STREET 1: 7373 WISCONSIN AVENUE STREET 2: SUITE 800 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 202-524-6851 MAIL ADDRESS: STREET 1: 7373 WISCONSIN AVENUE STREET 2: SUITE 800 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: SCOOP MEDIA, INC. DATE OF NAME CHANGE: 20111027 8-K 1 tm2414756d1_8k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 16, 2024 (May 15, 2024)

Global Medical REIT Inc.

(Exact name of registrant as specified in its charter)

Maryland	001-37815	46-4757266
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

7373 Wisconsin Avenue, Suite 800

Bethesda, MD

20814

(Address of principal executive offices)

(Zip Code)

(202) 524-6851

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class:		Trading Symbols:		Name of each exchange on which registered:
Common Stock, par value $0.001 per share		GMRE		NYSE
Series A Preferred Stock, par value $0.001 per share		GMRE PrA		NYSE

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e) As described below under Item 5.07, at the 2024 annual meeting of stockholders of Global Medical REIT Inc. (the “Company”) held on May 15, 2024 (the “2024 Annual Meeting”), the Company’s stockholders approved an amendment to the Company’s 2016 Equity Incentive Plan (the “Plan”) to increase the number of shares reserved for issuance thereunder by 1,500,000 shares, which was previously approved by the Company’s Board of Directors. The Plan is described in detail under “Proposal 4 – Amendment to 2016 Equity Incentive Plan” in the Company’s proxy statement filed with the U.S. Securities and Exchange Commission on April 1, 2024, and the foregoing description is qualified in its entirety by reference to the full text of the Plan, a copy of which is filed as Exhibit 10.1 to this Form 8-K and is incorporated herein by reference.

Item 5.07 Submission of Matters to a Vote of Security Holders.

At the 2024 Annual Meeting, the Company’s stockholders: (i) elected the seven nominated directors to the Company’s Board of Directors, each to serve until the Company’s 2025 annual meeting of stockholders and until her or his successor is duly elected and qualifies, (ii) approved, on an advisory basis, the compensation of the Company’s named executive officers, (iii) recommended, on an advisory basis, that future advisory votes on named executive officer compensation be conducted every year, (iv) approved an amendment to the Plan to increase the number of shares reserved for issuance thereunder by 1,500,000 shares, and (v) ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024. The full results of the matters voted on at the 2024 Annual Meeting are set forth below:

Proposal 1 — Election of Directors:

Nominee for Director		For		Against		Abstain		Broker Non-Votes
Jeffrey M. Busch		33,520,679		2,266,304		77,283		13,706,818
Matthew Cypher		34,365,340		1,417,356		81,570		13,706,818
Ronald Marston		34,271,830		1,506,912		85,523		13,706,819
Henry E. Cole		35,307,015		471,399		85,852		13,706,818
Zhang Huiqi		35,307,700		463,912		92,658		13,706,814
Paula R. Crowley		35,321,456		459,003		83,810		13,706,815
Lori Wittman		34,362,196		1,408,313		93,758		13,706,817

Proposal 2 — Advisory Vote on Named Executive Officer Compensation:

For		Against		Abstain		Broker Non-Votes
33,764,849		1,467,056		632,359		13,706,820

Proposal 3 — Advisory Vote on the Frequency of Future Advisory Votes on Named Executive Officer Compensation:

1 Year		2 Years		3 Years		Abstain		Broker Non-Votes
34,040,745		158,991		1,098,203		566,323		13,706,822

Proposal 4 — Amendment to the Company’s 2016 Equity Incentive Plan to Increase the Number of Shares Reserved for Issuance Thereunder by 1,500,000 Shares:

For		Against		Abstain		Broker Non-Votes
32,867,468		2,683,711		313,085		13,706,820

Proposal 5 — Ratification of Appointment of Independent Registered Public Accounting Firm:

For		Against		Abstain		Broker Non-Votes
48,840,222		608,585		122,277		0

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.	Description
10.1	Global Medical REIT Inc. 2016 Equity Incentive Plan (as amended through May 15, 2024) (incorporated by reference to Appendix A of Global Medical REIT Inc.'s Definitive Proxy Statement on Schedule 14A, filed on April 1, 2024)
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Global Medical REIT Inc.

	By:	/s/ Jamie A. Barber
		Jamie A. Barber
		Secretary and General Counsel

Date:  May 16, 2024

EX-101.SCH 2 gmre-20240515.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 3 gmre-20240515_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 4 gmre-20240515_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Class of Stock [Axis] Common Stock [Member] Series A Preferred Stock [Member] Statement [Table] Document Information [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 gmre-20240515_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 R1.htm IDEA: XBRL DOCUMENT

Cover	May 15, 2024
Document Information [Line Items]
Document Type	8-K
Amendment Flag	false
Document Period End Date	May 15, 2024
Entity File Number	001-37815
Entity Registrant Name	Global Medical REIT Inc.
Entity Central Index Key	0001533615
Entity Tax Identification Number	46-4757266
Entity Incorporation, State or Country Code	MD
Entity Address, Address Line One	7373 Wisconsin Avenue
Entity Address, Address Line Two	Suite 800
Entity Address, City or Town	Bethesda
Entity Address, State or Province	MD
Entity Address, Postal Zip Code	20814
City Area Code	202
Local Phone Number	524-6851
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity Emerging Growth Company	false
Common Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	GMRE
Security Exchange Name	NYSE
Series A Preferred Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	Series A Preferred Stock, par value $0.001 per share
Trading Symbol	GMRE PrA
Security Exchange Name	NYSE

EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 3 23 1 false 2 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://globalmedicalreit.com/role/Cover Cover Cover 1 false false All Reports Book All Reports gmre-20240515.xsd gmre-20240515_def.xml gmre-20240515_lab.xml gmre-20240515_pre.xml tm2414756d1_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tm2414756d1_8k.htm": { "nsprefix": "gmre", "nsuri": "http://globalmedicalreit.com/20240515", "dts": { "schema": { "local": [ "gmre-20240515.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "gmre-20240515_def.xml" ] }, "labelLink": { "local": [ "gmre-20240515_lab.xml" ] }, "presentationLink": { "local": [ "gmre-20240515_pre.xml" ] }, "inline": { "local": [ "tm2414756d1_8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 2, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 65, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 26 }, "report": { "R1": { "role": "http://globalmedicalreit.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-05-15", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2414756d1_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-05-15", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2414756d1_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "us-gaap_SeriesAPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesAPreferredStockMember", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Series A Preferred Stock [Member]" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://globalmedicalreit.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001104659-24-062602-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-24-062602-xbrl.zip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tm2414756d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001533615 2024-05-15 2024-05-15 0001533615 us-gaap:CommonStockMember 2024-05-15 2024-05-15 0001533615 us-gaap:SeriesAPreferredStockMember 2024-05-15 2024-05-15 iso4217:USD shares iso4217:USD shares false 0001533615 8-K 2024-05-15 Global Medical REIT Inc. MD 001-37815 46-4757266 7373 Wisconsin Avenue Suite 800 Bethesda MD 20814 202 524-6851 false false false false Common Stock, par value $0.001 per share GMRE NYSE Series A Preferred Stock, par value $0.001 per share GMRE PrA NYSE false